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Abstract  
Background: The Knee Injury and Osteoarthritis Outcome Score (KOOS) was 
constructed in Sweden. This questionnaire has proved to be valid for several 
orthopedic interventions of the knee. It has been formally translated and validated in 
several languages, but not yet in Dutch. The purpose of the present study was to 
evaluate the clinimetric properties of the Dutch version of the KOOS questionnaire in 
knee patients with various stages of osteoarthritis (OA).   
 
Methods: The Swedish version of the KOOS questionnaire was first translated into 
Dutch according to a standardized procedure and second tested for clinimetric quality. 
The study population consisted of patients with different stages of OA (mild, 
moderate and severe) and of patients after primary TKA, and after a revision of the 
TKA. All patients filled in the Dutch KOOS questionnaire, as well as the SF-36 and a 
Visual Analogue Scale for pain. The following analyses were performed to evaluate 
the clinimetric quality of the KOOS: Cronbach’s alpha (internal consistency), 
principal component analyses (factor analysis), intraclass correlation coefficients 
(reliability), spearman’s correlation coefficient (construct validity), and floor and 
ceiling effects.  
 
Results: For all patients groups Cronbach’s alpha was for all subscales above 0.70. 
The ICCs, assessed for the patient groups with mild and moderate OA and after 
revision of the TKA patients, were above 0.70 for all subscales. Of the predefined 
hypotheses 60% or more could be confirmed for the patients with mild and moderate 
OA and for the TKA patients for the other patient groups less than 45% could be 
confirmed. Ceiling effects were present in the mild OA group for the subscales Pain, 
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Symptoms and ADL and for the subscale Sport/Recreation in the severe OA group. 
Floor effects were found for the subscales Sport/Recreation and Qol in the severe OA 
and revision TKA groups. 
 
Conclusion: Based on these different clinimetric properties within the present study 
we conclude that the KOOS questionnaire seems to be suitable for patients with mild 
and moderate OA and for patients with a primary TKA. The Dutch version of the 
KOOS had a lower construct validity for patients with severe OA on a waiting list for 
TKA and patients after revision of a TKA. Further validation studies on the Dutch 
version of the KOOS should also include a knee specific questionnaire for assessing 
the construct validity. 
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Introduction 
There is consensus that patient-reported outcomes have additional value to clinical 
variables to evaluate patients’ health. The underlying principle is that functional status 
and quality of life can better be described by the patients themselves than by a 
physician [1]. With regards to knee surgery, however, at the start of the present study 
almost no reliable and validated Dutch versions of disease-specific questionnaires 
were available to evaluate the functional status of patients and quality of life after 
surgery. The Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC) is recommended for the assessment of treatment effects in patients with 
osteoarthritis (OA) and was developed for elderly with OA and assesses pain, 
stiffness and function in daily living [2-4]. 
Traumatic knee injuries often cause damage to structures such as ligaments, menisci 
and cartilage, and may lead to early development of OA. To be able to follow patients 
after a trauma and to monitor the changes in functional status and quality of life over 
time, a questionnaire is needed which covers both the short and long-term 
consequences of an injury of the knee [5]. In other words, there is a clear need for an 
instrument that not only monitors the outcome in elderly knee OA patients, but also 
monitors the consequences of acute knee injury in physically active patients in their 
early adulthood.  
Therefore, Roos et al. developed such a questionnaire in Sweden [6,7]. The Knee 
Injury and Osteoarthritis Outcome Score (KOOS) evaluates the functional status and 
quality of life of patients with any type of knee injury who are at increased risk to 
develop OA; i.e. patients with anterior cruciate ligament (ACL) injury, meniscus 
injury or chondral injury. Until now, the KOOS questionnaire has been validated for 
several orthopedic interventions such as ACL reconstruction [7], total knee 
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arthroplasty (TKA) [8], and menisectomy [9]. It has been formally translated and 
validated in several languages, but not yet in Dutch.  
The purpose of this study was therefore to translate the KOOS questionnaire into 
Dutch and to evaluate the clinimetric properties of the Dutch version of the KOOS 
questionnaire, in terms of internal consistency, reliability, validity, and floor and 
ceiling effects.  
We studied the Dutch version of the KOOS in patients with different stages of OA: 
mild, moderate and severe OA and in patients after a primary TKA and after revision 
of the TKA.    
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Methods 
The study was divided into two stages. First, the Swedish version of the KOOS 
questionnaire was translated into Dutch according to a standardized procedure [10]. 
Second, the translated version was tested for clinimetric quality in a prospective 
study.  
  
Procedure of translation 
The procedure of translation included three steps [11]. First two persons (T1 and T2) 
translated independently of each other the Swedish version of the KOOS 
questionnaire into Dutch (forward translation); one translator had a technical 
background and the other had a medical background; both were native Dutch 
speakers. Based on a consensus meeting one final version (T-12) was formed [10].  
Second, two bilingual persons (T3 and T4), one with a background in education and 
the other with a chemical background, both native Swedish speakers, independently 
re-translated this Dutch version (T-12) into Swedish (backward translation). They 
were blind to the original Swedish version. 
Finally, all translators had a consensus meeting to consolidate the final version of the 
Dutch version of the KOOS questionnaire, which was used in the present study. This 
final version was presented to a subset of 15 patients suffering from knee complaints. 
These patients were asked whether they understood all items and whether they had 
any problems with the formulation of the items on the Dutch version of the KOOS 
questionnaire. None of the patients reported problems with the items of the KOOS 
questionnaire.  
 7 
Patients 
We used five patient groups with different stages of OA of the knee of the knee, based 
on clinical and radiographic signs, to evaluate the clinimetric properties of the Dutch 
version of the KOOS questionnaire. All patients were under medical treatment at the 
department of Orthopedics at the Erasmus Medical Center in Rotterdam between 
1990 and 2005.  
The first patient group consisted of patients with mild OA, who had undergone ACL 
reconstruction between 1994 and 1996. The second patient group consisted of patients 
with moderate OA who had undergone HTO between 1998 and 2000. All patients in 
this group had a valgus correction within a range of 5 to 14 degrees. The third patient 
group consisted of patients with severe OA who were on the waiting list for a TKA. 
The fourth patient group consisted of patients 6 months after a TKA, who were 
operated between 2004 and 2006. The fifth patient group consisted of patients who 
had undergone a revision of the primary TKA because of a failure of the primary 
TKA between 2001 and 2006. Patients unable to understand Dutch written language 
were excluded. The Medical Ethics Committee at the Erasmus Medical Center 
approved all studies. The choice of our study population, except for the TKA 
population, was based on existing retrospective cohort studies.  
 
All participants were asked to complete three questionnaires at home: the Dutch 
KOOS, the SF-36 [12], and a Visual Analogue Scale for pain [13] between June 2004 
and July 2006. They were asked to fill in the Dutch KOOS at home again after two till 
three weeks. For test-retest studies the time interval needs to be sufficiently short to 
support the assumption that the patients remain stable and to be sufficiently long to 
prevent recall [14]. We considered a time interval of three weeks to be appropriate for 
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these patient populations. The local Medical Ethics Committee approved the study 
and all participants gave their written informed consent. 
 
Questionnaires 
KOOS 
The KOOS questionnaire covers five dimensions that are reported separately: Pain 
(nine items), Symptoms (seven items), activities of daily living (ADL, 17 items), sport 
and function (Sport/recreation, five items), and knee-related quality of life (QoL, four 
items). Standardized answer options are provided and each question is rated on a scale 
from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating 
extreme symptoms) is then calculated for each subscale. The format is user-friendly 
and the questionnaire takes about 10 minutes to complete. The KOOS questionnaire is 
self-explanatory and can be administrated in the waiting room or used as a mailed 
survey [7]. The KOOS questionnaire includes the WOMAC Osteoarthritis Index LK 
3.0 [2,3] in its complete and original format (with permission), and WOMAC scores 
can be calculated. The WOMAC is worldwide used in elderly subjects with knee or 
hip OA [2]. The Dutch version of the WOMAC is validated for hip OA patients [15]. 
 
Short Form-36 (SF-36) 
The SF-36 is a generic health status questionnaire that contains 36 items. It measures 
eight dimensions (bodily pain; physical function; social function; role limitations 
because of physical problems; role limitations because of emotional problems; mental 
health; vitality; general health perceptions) and is widely used, has shown to be 
reliable and valid in the Dutch general population, and is easy to complete [1,16].  
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Visual analogue scale for pain 
The Visual Analogue Scale (VAS) for pain is a simple way of measuring the intensity 
of pain. The 100-mm VAS is a unidimensional scale that is versatile, easy to use, and 
has been adopted in many settings. It has shown to be valid and reliable [13]. 
 
Statistical analysis 
 
 Internal consistency 
A high degree of homogeneity is desirable in a scale. This has two implications: 1) the 
items should be at least moderately correlated with each other, and 2) each item 
should correlate above 0.20 with the total scale score [14]. These two factors form the 
basis of the various tests of homogeneity or internal consistency of the scale. The 
internal consistency was determined by calculating Cronbach’s alpha. The widely 
accepted cut-off is that Cronbach’s alpha should be 0.70 or higher for a set of items to 
be considered a (sub) scale [14,17]. 
 
Factor analysis 
Factor analysis is a technique designed to reveal whether or not the pattern of 
responses on a number of tests can be explained by a smaller number of underlying 
traits or factors, with each factor reflecting a different construct [14]. Streiner et al. 
noted that an absolute minimum of five subjects per variable is necessary, with the 
proviso that there are at least 100 subjects. Exploratory factor analyses were 
conducted on all KOOS items using principal component analyses (PCA) with 
varimax rotation on the combined study population, because all subgroups had a 
number lower than 100. We first extracted factors with eigenvalues greater than 1. 
Next, we carried out a forced five, four, three, two and one factor solution. 
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First, we identified the number of meaningful factors based on the Scree plot and on 
the interpretation of the factor solutions. Using the Scree plot, we looked for a break 
between the factors with relatively large eigenvalues and those with smaller 
eigenvalues. Factors that appeared before the break were assumed to be meaningful, 
and factors that appeared on the approximately horizontal line after the break were 
considered to account for only a trivial amount of variance and were therefore not 
considered meaningful. Second, we looked at the factor structure and factor loadings 
after varimax rotation. Items with a factor loading less than 0.50 on all factors could 
be considered for exclusion. In other words factor analysis was performed in order to 
determine whether the KOOS questionnaire actually consists of 5 subscales.  
 
Reliability 
Reliability involves the degree to which the results of measurement are consistent 
across repeated measurements [14]. To estimate the test-retest reliability of the Dutch 
KOOS subscales, we calculated intraclass correlation coefficients (ICCs) with a 95% 
confidence interval (95% CI). Due to practical problems we only assed the test-retest 
reliability at the mild and moderate OA group and the revision TKA group. We used 
the ICC two-way random effects model type agreement to measure the reliability 
[18]. The ICC is generally considered to be good at 0.70 and above [14]. The standard 
error of measurement (SEM) is a measure of the absolute measurement error of a 
score, expressed in the unit of measurement of the instrument [19]. The SEM was 
calculated as the square root of the sum of the between administration variance and 
the residual variance [20].  
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Validity 
Validity is the degree to which an instrument measures the construct it is intended to 
measure. Because of the absence of a gold standard the validity was expressed in 
terms of construct validity, which concerns the extent to which a particular measure 
relates to other measures consistent with theoretically derived hypotheses for the 
constructs that are being measured [21]. The construct validity of the KOOS 
questionnaire was determined by comparing its results with the generic SF-36 and the 
VAS for pain.  
Hypotheses were formulated about the expected magnitude and direction of 
relationships between the subscales of the KOOS questionnaire and the other 
instruments. The formulation of the hypotheses was based on the starting point that 
there is a clear distinction between the subscales of the KOOS questionnaire. We 
defined the construct validity of the KOOS questionnaire as good if > 75% of the 
hypotheses could be confirmed [22], moderate in case of 50-75% confirmation, and 
low when under 50% of confirmation. To evaluate the construct validity of the Dutch 
KOOS version, Spearman’s correlations were calculated.  
 
We formulated four hypotheses about convergent relations between the KOOS 
questionnaire, SF-36 and VAS for pain. The correlation between KOOS Pain and SF-
36 BP, between KOOS Pain and SF-36 PF, KOOS (all subscales) and VAS for Pain 
and KOOS ADL and SF-36 PF should be ≥ 0.60. We expected that KOOS Pain has a 
stronger correlation with SF-36 BP compared to the correlation with SF-36 PF. This 
difference should be at least 0.05 higher. We further expected that KOOS Pain has a 
stronger correlation with VAS for pain compared to the correlation of the other 
subscales of the KOOS with the VAS for Pain. This difference should be at least 0.05 
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higher. KOOS ADL was expected to have a 0.05 higher correlation with SF-36 PF 
compared to the correlation of the other subscales of the SF-36.  
We formulated five hypotheses about divergent relations between all subscales of the 
KOOS questionnaire and SF-36 GH: with correlations of ≤ 0.30. All other 
correlations between the KOOS subscales and the SF-36 should be higher than 0.30 
and lower than 0.60. 
 
Floor and ceiling effects 
The presence of floor and ceiling effects may influence the reliability, validity and 
responsiveness of an instrument. An intervention effect might be missed for people 
who occupy the maximum score. Floor and ceiling effects were considered present if 
more than 15% of the respondents achieved the highest or lowest possible score [22].  
 
Data were analysed with SPSS statistical software version 10.1. The level of 
significance for all statistical procedures was p < 0.05. 
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Results 
Table 1 presents the characteristics of five patient groups. The first patient group 
consisted of 36 patients with mild OA  (response rate of 79%). All patients filled in 
the questionnaires for the cross-sectional validity. For the test-retest reliability 35 
patients filled in the KOOS questionnaire twice. The second patient group consisted 
of 62 patients with moderate OA (response rate of 76%) who filled in the 
questionnaires for the cross-sectional validity. Of these patients 53 filled in the KOOS 
questionnaire twice for the test-retest reliability. The third patient group consisted of 
47 patients with severe OA (response rate of 54%). The fourth group consisted of 63 
TKA patients  (response rate of 77%) and the fifth group of 54 patients with a revision 
of the TKA (response rate of 75%). These patients filled in all questionnaires for the 
cross-sectional validity and 47 patients filled in the KOOS questionnaire twice for the 
test-retest reliability.  
  
Internal consistency 
Table 2 presents the internal consistency expressed by Cronbach’s alpha. For all 
patients groups Cronbach’s alpha was for all subscales above 0.71, indicating a good 
internal consistency of all items in these scales and subscales. Except for the subscale 
Symptoms in the severe OA group a Cronbach’s alpha of 0.56 was found, which 
indicates a moderate internal consistency.  
Factor analysis 
The Scree plot showed a distinct break before factor 3, suggesting that only the first 
two factors were meaningful enough to be retained. This indicates that two factors 
may be adequate to describe the data. This initial solution accounted for 64% of the 
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total variance for the Dutch version of the KOOS questionnaire (eigenvalue of 21.5 for 
the first factor and 3.7 for the second factor). However, in the two-factor solution, 
many items loaded on both factors. Therefore, we chose a forced one-factor solution, 
which accounted for 51.0% of the variance. The loading factors ranged from 0.37 - 
0.85. The loading factor of the question S4 was lower than 0.40.   
 
Reliability 
Table 3 presents the ICCs of all subscales of the KOOS questionnaire for patient 
groups with mild and moderate OA and after revision of the TKA patients. In these 
patient groups the ICCs were 0.70 or higher, indicating a good reliability. Only an 
ICC of 0.45 was found for the subscale Sport/recreation in the revision TKA group.  
The SEM ranged for the mild OA group between 5.2 and 9.0, for the moderate OA 
group between 5.8 and 11.6 and for patients after revision of the TKA between 7.2 
and 24.6.  
 
Validity 
Of the predefined hypotheses 60% or more could be confirmed for the study groups 
with mild OA and moderate OA and for the TKA patient population. For the severe 
OA group and the revision TKA group less than 45% could be confirmed. Tables 
4,5,6,7 and 8 show the correlations between the KOOS subscales, the SF-36 subscales 
and the VAS for pain. Overall, the highest correlations between the KOOS subscales 
and the SF-36 bodily pain and physical function were found. Correlations between the 
KOOS subscale Pain and the VAS-pain were between r = −0.28 and −0.79.  
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Floor and ceiling effects 
Neither floor effects (indicating worst possible score) nor ceiling effects (indicating 
best possible score) were found for the patients with moderate OA patients and the 
TKA patients (Table 9). Only ceiling effects were present in the mild OA group for 
the subscales Pain, Symptoms and ADL and for the subscale Sport/Recreation in the 
severe OA TKA group. Floor effects were found for the subscales Sport/Recreation 
and Qol in the severe OA and revision TKA. 
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Discussion 
 
The results of this validation study of the Dutch KOOS questionnaire showed a good 
internal consistency for all study groups. Reliability was also good in the mild and 
moderate OA group and the revision TKA group. It was not assessed the patients with 
severe OA and patients with a TKA. The construct validity was moderate for the 
patient groups with mild and moderate OA and for TKA patients, and lower for the 
severe OA and revision TKA patients. Ceiling effects were present in the mild OA 
group and in the severe OA group. Floor effects were seen in the patient group with 
severe OA group and the revision TKA group.  
 
In this validation study Cronbach’s alphas were above 0.70 for almost all subscales in 
our patient groups. This indicates a good internal consistency, which is in line with 
the study of Roos et al. [6,8]. However, for the subscale Symptoms in the severe OA 
population we found a Cronbach’s of 0.56, indicating a moderate internal consistency. 
Deleting one or more questions did not result in a higher internal consistency. Kessler 
et al. and Xie et al. also found a lower Cronbach’s alpha (<0.70) for this subscale in 
patients with OA of the knee [23,24]. 
 
In our study, factor analysis was performed on the whole study population and we 
found that all items of the Dutch version of the KOOS questionnaire loaded on one 
factor. Our results are in contrast with the conclusion of Roos et al. that the KOOS 
items loaded on five factors [6]. However, our findings are in line with Thumboo et 
al. and Faucher et al. who claimed that the subscales Pain and Physical function of the 
WOMAC loaded on the same factor [25-28]. In the present study, the factor loading 
of the question S4 (can you straighten your leg fully) was lower than 0.40 which 
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suggests that this item might be excluded from the questionnaire. Despite our 
preliminary results indicating that the Dutch version of the KOOS questionnaire 
contains one single factor, we retained in our analyses the original subscales of the 
Swedish version of the KOOS questionnaire. However, based on our findings we 
recommend additional factor analyses on other data sets, before changing the number 
of subscales of the Dutch version of the KOOS questionnaire. 
 
In the present study the test-retest reliability was good for the patient groups with mild 
OA (ICC 0.74–0.88), moderate OA (ICC 0.87-0.94) and patients after a revision TKA 
(ICC 0.73-0.89). A lower ICC (0.45) for patients after a revision TKA for the subscale 
Sport/recreation was found. When deleting all outliers the ICC is still smaller then 
0.70 (ICC 0.62). It is plausible that for these older patients questions about sport and 
recreation are less relevant.  
 
The construct validity of the KOOS questionnaire was determined by comparing the 
KOOS subscales with the subscales of the SF-36 and the VAS for pain. Correlations 
between subscales, which measure the same construct, were compared. In our study 
we found the highest correlations between the KOOS subscales and the SF-36 
subscales which are intended to measure the same constructs. Within the TKA patient 
group we found some higher correlation coefficients compared to the study of Roos et 
al. (ADL vs PF r = 0.83 vs 0.48 and Pain vs PF r=0.66 vs 0.19) [8]. The correlations 
we found within the severe OA patient group (ranging from r = 0.12 to 0.57) were 
lower than found by Xie et al. They found correlations between r = 0.37 and 0.65 for 
the English version and r = 0.24 and 0.64 for the Chinese version of the KOOS [24]. 
Kessler et al. compared the subscales of the KOOS with the SF-12 for the same 
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population and found a low correlation between the subscale Symptoms and the SF-
12 (r= 0.05); the other subscales showed correlations of 0.60 or higher [23]. 
By only reporting the correlations coefficients it is not clear whether the construct 
validity of a questionnaire is sufficient or not. Therefore Terwee et al. developed 
quality criteria for design, methods and outcomes of studies to compare the 
measurement properties of health status questionnaires [22]. These authors 
recommended assessing the construct validity by testing predefined hypotheses (e.g., 
about expected correlations between measures or expected differences in scores 
between ‘known’ groups). Without specific hypotheses there is a risk of bias, because 
retrospectively it is tempting to generate alternative explanations for low correlations 
instead of concluding that the questionnaire may not be valid. Terwee et al. give a 
positive rating for construct validity if hypotheses are specified in advance and at least 
75% of the results are in correspondence with these hypotheses [22]. Our choice that 
convergent correlations should have a correlation coefficient of ≥ 0.60 and divergent 
correlations of ≤ 0.30 is arbitrary. However, there is no consensus in literature how to 
deal with this issue. From our pre-defined hypotheses 60% or more could be 
confirmed in both the mild and moderate OA group and in patients after a TKA 
(moderate construct validity). Less than 45% from our hypotheses could be confirmed 
for patients with severe OA and after a revision TKA  (lower construct validity).  
 
The formulation of the hypotheses was based on the starting point that there is a clear 
distinction between the subscales of the KOOS questionnaire. However, with factor 
analysis we found that all items of the Dutch version of the KOOS questionnaire seem 
to load on one factor. This may explain the overlap between the correlations of the 
different constructs of the KOOS questionnaire with the SF-36. This is most obvious 
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for the subscales Pain and ADL of the KOOS in relation to the subscales BP and PF 
of the SF-36. Previous studies showed that the WOMAC subscale pain and physical 
function loaded on the same factor [25-27]. Apparently it is difficult for patients to 
make a distinction between questions about pain and physical functioning in ADL. In 
our opinion this can be ascribed to the formulation of the questions; the term difficulty 
(translated in Dutch: ‘moeite’) may be not clear for some patients. The meaning of 
this term should be clarified or re-formulated. This was also suggested by Stratford et 
al, and Terwee et al. [29,30]. 
 
Because it is known that clinimetric properties are variable in different study 
populations [14], it is recommended to validate a questionnaire in the target 
population. This study showed that the clinimetric properties of the Dutch version of 
the KOOS questionnaire differed between the 5 different patient groups, which 
confirms the above described recommendation. Additionally, in future validation 
studies of the KOOS questionnaire, it may be of interest to evaluate the validity of the 
Dutch KOOS questionnaire by comparing the subscales of the KOOS questionnaire 
with the Dutch Oxford 12-item knee questionnaire. This latter questionnaire was 
considered to be valid and reliable in patients with OA of the knee [31]; however, it 
was not validated when we started the present study.  
 
We observed ceiling effects only in the mild OA patient group for the subscales Pain, 
Symptoms and ADL of the KOOS questionnaire. It is plausible that these patients 
have few complaints of their knee and have no or minor clinical signs of OA, which 
can explain the presence of ceiling effects in this group of patients. Floor effects were 
only found in the subscale Sport/recreation in the patients with severe OA and in 
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patients after revision of the TKA. Roos et al. stated that questions about sport and 
recreation also are relevant for older patients [8]. However, this does not seem to 
apply for patients after revision of the TKA. Because of severity of the disease and/or 
higher age, it is plausible that these patients do not participate in sport and 
recreational activities. Dividing the revision population into those younger than 65 
years and older than 65 years resulted in floor effects of over 50% in the older 
patients. Questions about sport may be more relevant to younger patients than to older 
patients. Because the KOOS questionnaire was originally developed for younger 
patients this finding is not surprising.  
 
Our study is not without limitations. First, because the selection of patients in the 
present study only allows statements on the reliability and validity of the KOOS 
questionnaire in patients with different stages of OA and it’s treatment. The 
questionnaire was not studied in patients after a menisectomie or an ACL 
reconstruction. The results of the present study could not be generalized to patients 
with an acute knee trauma.  
Second, a measurement tool can also be used to monitor the efficacy of an 
intervention or the disease process of the patient. For this goal the tool needs to be 
sensitive to detect clinically relevant changes during a certain period of time 
(responsiveness). ICCs are strongly influenced by the heterogeneity of the study 
population.  
The interpretation of the SEM, i.e. whether it should be regarded as a large or a small 
measurement error, depends on what changes are minimal important on the KOOS 
subscales. The smallest detectable change (defined as 1.96*√2*SEM) has to be 
smaller than the minimal important changes [20].  Future studies should look at what 
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changes in scores on the KOOS subscales constitutes minimal important change. In 
addition, the responsiveness of the KOOS questionnaire needs to be evaluated in a 
future study.  
 
Conclusion 
Based on these different clinimetric properties within the present study we conclude 
that the KOOS questionnaire seems to be suitable for patients with mild and moderate 
OA and for patients with a primary TKA. The Dutch version of the KOOS had a 
lower construct validity for patients with severe OA on a waiting list for TKA and 
patients after revision of a TKA. However, the construct validity is only assessed by 
comparing it with the SF-36 and the VAS for pain, not with a knee specific 
questionnaire. Further validation studies on the Dutch version of the KOOS should 
include knee specific questionnaires for assessing the construct validity.   
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Table1Characteristics of the five patient groups 
 Mild OA  
(n=36) 
Moderate OA 
(n=62) 
Severe OA    
(n=47) 
TKA 
(n=63) 
Revision of 
TKA  
(n=54) 
Age in years 36 (27-50) 56 (27-72) 65 (42-81) 61(42-78) 77 (36-89) 
Gender,  
women % 
22 32 52 51 78 
VAS pain  0.7 (0.0-6.7) 3.9 (0.0-10.0) 6.1 (1.0-10.0) 1 (0.0-9.4) 5.0 (0-10) 
KOOS 
Pain 
Symptoms 
ADL 
Sport/recreation 
QoL 
 
 
85.3 ± 18.5 
78.6 ± 7.1 
91.2 ± 15.1 
71.0 ± 23.4 
67.0 ± 21.6 
 
 
62.9 ± 25.7 
63.2 ± 24.4 
69.3 ± 24.2 
36.2 ± 32.0 
44.6 ± 26.3 
 
41.8 ± 18.9 
46.4 ± 18.7 
43.4 ± 19.4 
29.1 ± 39.2 
30.9 ± 25.5 
 
70.1 ± 24.5 
72.3 ± 18.5 
72.8 ± 23.3 
33.2 ± 24.1 
52.2 ± 23.8 
 
61.6 ± 23.4 
64.7 ± 21.5 
56.6 ± 21.9 
26.8 ± 34.1 
36.6 ± 26.6 
SF-36 
BP 
PF 
SF 
RF 
RE 
MH 
VT 
GH 
 
84.7 ± 19.7 
86.4 ± 17.2 
92.4 ± 10.5 
77.8 ± 38.2 
91.7 ± 25.7 
86.8 ± 13.4 
75.4 ± 13.4 
84.0 ± 12.8 
 
63.6 ± 24.0 
61.1 ± 24.8 
82.8 ± 21.9 
64.8 ± 39.7 
87.4 ± 28.5 
79.6 ± 19.2 
68.9 ± 19.3 
65.0 ± 20.8 
 
34.6 ± 22.1 
34.9 ± 20.6 
61.7 ± 28.1 
26.6 ± 34.7 
57.4 ± 44.3 
69.1 ± 20.0 
53.9 ± 19.3 
60.2 ± 23.0 
 
70.7 ± 24.9 
61.7 ± 23.9 
81.8 ± 28.6 
57.4 ± 43.7 
69.7 ± 43.6 
74.6 ± 21.7 
66.5 ± 21.8 
66.8 ± 24.1 
 
55.4 ± 27.2 
32.9 ± 24.4 
64.1 ± 29.0 
31.0 ± 38.8 
59.9 ± 42.6 
70.3 ± 20.7 
55.5 ± 19.1 
51.4 ± 21.3 
Results are presented as median (range) or mean ± SD. Abbreviations: OA; osteoarthritis, TKA; total 
knee arthroplasty, Revision of TKA; Revision of total knee arthroplasty; VAS, Visual Analogue Scale; 
BP, bodily pain; PF, physical function; SF, social function; RF, role limitations because of physical 
problems; RE, role limitations because of emotional problems; MH, mental health; VT, vitality; GH, 
general health perception; ADL, Activities of daily living; QoL, Quality of life.  
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Table2 Internal consistency of the KOOS subscales, expressed by Cronbach’s alpha 
KOOS subscales  Mild OA Moderate 
OA  
Severe OA   TKA Revision of 
TKA 
Pain (9 items) 0.94 0.93 0.80 0.92 0.87 
Symptoms (7 items) 0.71 0.83 0.56 0.74 0.78 
ADL (17 items) 0.78 0.97 0.94 0.94 0.93 
Sport/Recreation  
(5 items) 
0.87 0.95 0.98 0.88 0.95 
QoL (4 items) 0.81 0.85 0.73 0.81 0.90 
Abbreviations:  OA; osteoarthritis, TKA; total knee arthroplasty, Revision of TKA; Revision  
of total knee arthroplasty, ADL, Activities of daily living; QoL; Quality of life.  
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Table 3 Reliability of all subscales of the KOOS  
  Baseline 
mean 
(SD) 
Retest 
mean 
(SD) 
Change 
scores 
mean 
(SD) 
SEM ICC 
agreement 
95% CI 
Mild OA  
(n=35)  
Pain 85.3 
(18.5) 
89.7 
(12.5) 
-4.4  
(9.4) 
7.2 0.80 0.60-0.90 
 
Symptoms 78.6 
(7.1) 
81.3 
(16.8) 
-2.2 
(12.8) 
9.0 0.74 0.54-086 
 
ADL 91.2 
(15.1) 
93.5 
(10.8) 
-2.3  
(7.1) 
5.2 0.85 0.71-0.92 
 
Sport 
/recreation 
71.0 
(23.4) 
73.0 
(22.9) 
-1.7 
(12.8) 
9.0 0.85 0.73-0.92 
 
QoL 67.0 
(21.6) 
69.6 
(20.5) 
-2.5 
(10.3) 
7.4 0.88 0.77-0.94 
Moderate 
OA  
(n=53) 
Pain 62.9 
(25.7) 
63.2 
(23.7) 
0.0  
(12.9) 
9.0 0.87 0.78-0.92 
 
Symptoms 63.2 
(24.4) 
66.2 
(21.9) 
-1.5 
(11.3) 
8.0 0.87 0.79-0.92 
 
ADL 69.3 
(24.2) 
69.2 
(23.7) 
0.6  
(8.2) 
5.8 0.94 0.90-0.97 
 
Sport 
/recreation 
 
36.2 
(32.0) 
 
39.7 
(32.5) 
 
-4.8 
(15.9) 
 
11.6 
 
0.87 
 
0.78-0.92 
 
QoL 44.6 
(26.3) 
47.3 
(25.4) 
-2.1 
(10.3) 
7.4 0.91 0.86-0.95 
Revision of 
TKA  
(n=47) 
Pain 61.6 
(23.4) 
63.9 
(21.9) 
-2.3 
(14.3) 
10.1 0.80 0.67-0.88 
 
Symptoms 64.7 
(21.5) 
62.9 
(21.7) 
1.7  
(10.2) 
7.2 0.89 0.81-0.94 
 
ADL 56.6 
(21.9) 
59.5 
(22.9) 
-2.9 
(16.4) 
11.7 0.73 0.56-0.83 
 
Sport 
/recreation 
 
26.8 
(34.1) 
 
27.4 
(34.2) 
 
-2.2 
(35.1) 
 
24.6 
 
0.45 
 
0.19-0.66 
 
QoL 36.6 
(26.6) 
40.3 
(27.5) 
-3.7 
(14.9) 
10,8 0.84 0.73-0.91 
Abbreviations: OA; osteoarthritis, SD, standard deviation; SEM, standard error of measurement; ICC 
agreement, intraclass correlation coefficient for agreement; CI, confidence interval. A normalized score 
(100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. 
Revision of TKA; Revision of total knee arthroplasty, AD; Activities of daily living; QoL; Quality of 
life.  
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Table 4 Validity of the KOOS for the patient group with mild OA   
 KOOS  
Pain 
KOOS 
Symptoms 
KOOS  
ADL 
KOOS 
Sport/Rec 
KOOS 
 QOL 
SF-36 
Subscale 
     
BP 0.60*  0.44 0.63  0.41 0.38 
PF 0.64  0.53 0.63* 0.46 0.56 
SF 0.23 0.13 0.25 0.09 0.26 
RF 0.28 0.37 0.35 0.36 0.40 
RE 0.31 0.24 0.19 0.25 0.24 
MH 0.42 0.20 0.42 0.30 0.38 
VT 0.42 0.27 0.37 0.34 0.31 
GH 0.34  0.28  0.35  0.30  0.30  
VAS for 
pain 
-0.79* -0.71 -0.78 -0.57 -0.59 
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-
pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, 
role limitations because of physical problems; RE, role limitations because of emotional problems; 
MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, 
Quality of life. In bold: convergente correlations that should be > 0.60, In Italic: divergente correlations 
that should be < 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations 
marked by * have to be 0.05 higher than the other convergent correlations. 
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Table 5 Validity of the KOOS for the patient group with moderate OA  
 KOOS  
Pain 
KOOS 
Symptoms 
KOOS  
ADL 
KOOS 
Sport/Rec 
KOOS 
 QOL 
SF-36 
Subscale 
     
BP 0.63* 0.57 0.71 0.43 0.62 
PF 0.72 0.60 0.75* 0.60 0.70 
SF 0.36 0.48 0.50 0.05 0.42 
RF 0.23 0.32 0.36 0.12 0.26 
RE 0.33 0.39 0.41 0.16 0.46 
MH 0.23 0.36 0.27 -0.01 0.25 
VT 0.37 0.35 0.48 0.05 0.37 
GH 0.32 0.22 0.32 0.13 0.29 
VAS for 
pain 
-0.69* -0.57 -0.69 -0.38 -0.75 
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-
pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, 
role limitations because of physical problems; RE, role limitations because of emotional problems; 
MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, 
Quality of life. In bold: convergente correlations that should be > 0.60, In Italic: divergente correlations 
that should be < 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations 
marked by * have to be 0.05 higher than the other convergent correlations. 
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Table 6 Validity of the KOOS for the patient group with severe OA  
 KOOS  
Pain 
KOOS 
Symptoms 
KOOS  
ADL 
KOOS 
Sport/Rec 
KOOS 
 QOL 
SF-36 
Subscale 
     
BP 0.57* 0.55 0.72 0.37 0.47 
PF 0.36 0.27 0.54* 0.12 0.22 
SF 0.36 0.42 0.33 0.12 0.49 
RF 0.28 0.21 0.37 0.04 0.32 
RE 0.13 0.18 0.28 -0.04 0.25 
MH 0.11 0.12 0.36 -0.07 0.18 
VT 0.26 0.24 0.46 0.10 0.29 
GH 0.14 0.03 0.21 -0.11 0.16 
VAS for 
pain 
-0.28* -0.43 -0.29 -0.19 -0.19 
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-
pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, 
role limitations because of physical problems; RE, role limitations because of emotional problems; 
MH, mental health; VT, vitality; GH, general health perception, ADL; Activities of daily living, QoL; 
Quality of life. In bold: convergente correlations that should be > 0.60, In Italic: divergente correlations 
that should be < 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations 
marked by * have to be 0.05 higher than the other convergent correlations. 
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Table 7 Validity of the KOOS for the patient group with a primary TKA  
 KOOS  
Pain 
KOOS 
Symptoms 
KOOS  
ADL 
KOOS 
Sport/Rec 
KOOS 
 QOL 
SF-36 
Subscale 
     
BP 0.62* 0.58 0.72 0.48 0.62 
PF 0.66 0.56 0.83* 0.67 0.64 
SF 0.39 0.35 0.48 0.26 0.51 
RF 0.53 0.53 0.68 0.57 0.49 
RE 0.22 0.27 0.39 0.37 0.23 
MH 0.46 0.46 0.52 0.37 0.52 
VT 0.61 0.48 0.52 0.31 0.49 
GH 0.43 0.41 0.49 0.31 0.55 
VAS for 
pain 
-0.70* -0.58 -0.59 -0.51 -0.27 
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-
pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, 
role limitations because of physical problems; RE, role limitations because of emotional problems; 
MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, 
Quality of life. In bold: convergente correlations that should be > 0.60, In Italic: divergente correlations 
that should be < 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations 
marked by * have to be 0.05 higher than the other convergent correlations. 
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Table 8 Validity of the KOOS for the patient group with a revision of the TKA   
 KOOS  
Pain 
KOOS 
Symptoms 
KOOS  
ADL 
KOOS 
Sport/Rec 
KOOS 
 QOL 
SF-36 
Subscale 
     
BP 0.49* 0.39 0.50 0.30 0.54 
PF 0.26 0.20 0.44* 0.32 0.36 
SF 0.20 0.11 0.24 0.16 0.42 
RF 0.12 0.18 0.14 0.24 0.26 
RE 0.10 0.09 0.00 -0.01 0.15 
MH 0.15 0.26 0.21 0.05 0.28 
VT 0.15 0.28 0.18 0.05 0.39 
GH 0.09 0.27 0.24 0.22 0.33 
VAS for 
pain 
-0.47* -0.47 -0.29 -0.30 -0.21 
Validity is expressed by Spearman correlations between KOOS subscales, SF-36 subscales and VAS-
pain. Abbreviations: OA; osteoarthritis, BP, bodily pain; PF, physical function; SF, social function; RF, 
role limitations because of physical problems; RE, role limitations because of emotional problems; 
MH, mental health; VT, vitality; GH, general health perception; ADL, Activities of daily living; QoL, 
Quality of life. In bold: convergente correlations that should be > 0.60, In Italic: divergente correlations 
that should be < 0.30. All other hypotheses are expected to be between 0.30 and 0.60. Correlations 
marked by * have to be 0.05 higher than the other convergent correlations. 
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Table 9 Percentage ceiling/floor effects of the KOOS (best possible score/worst possible score)  
 Pain Symptoms ADL Sport/ 
Recreation 
QoL 
Mild OA  (n=36) 28/0 22/0 42/0 14/0 11/0 
Moderate OA (n=62) 13/2 3/0 8/0 10/11 5/2 
Severe OA  (n=47) 0/2 0/2 0/0 20/38 0/15 
TKA (n=63) 10/0 3/0 7/0 0/7 6/3 
Revision of TKA (n=54) 2/0 4/0 2/0 6/38 4/4 
Abbreviations:  OA; osteoarthritis, Revision of TKA, Revision of total knee arthroplasty;  
ADL, Activities of daily living; QoL, Quality of life.  
 
 
 
 
 
 
